You searched for "imaging"
How can we be SMART with virtual consultations?
At the beginning of 2020, video conferencing and phone consultations accounted for less than 1% of all consultations. Now it is probably 70%. Whilst there are many remote consultation solutions available, Tina Marshall describes what the ideal solution should look...What is new in lasers for endourology: looking into the future
From the first cystoscopic argon and neodymium-YAG (yttrium-aluminium-garnet) laser used for bladder tumours in 1976 by Staehler et al. [1], lasers have proven to be a versatile and an evolving tool in the therapeutic management of a variety of urological...Penile Mondor’s disease
Mondor’s disease is a rare, self-limiting entity characterised by subcutaneous chord like bands throughout the body. These bands arise due to phlebitis of the subcutaneous vessels. Penile Mondor’s disease (PMD) is an isolated superficial thrombophlebitis of the superficial dorsal vein...Submit your abstract for SIU 2025 today!
Present your innovative research on the world stage! 🌟 Submit your abstract for SIU 2025 Edinburgh by April 3 2025, and be part of shaping the future of urology. Click the image to accessRSM: Training, Transformation, Excellence: The Surgeon’s Cycle of Life
Royal Society of Medicine Training, Transformation, Excellence: The Surgeon’s Cycle of LifeInterview with Miguel Aragon for Urology News
- Sponsored Content - Continence health conditions affect a large portion of Europe’s population, with impacts at both the personal and societal level. Although urinary incontinence is very common, it remains an undertreated condition. During World Continence Week, we discussed...Erection pills may improve heart conditions and diabetes but are underused – Prostate Cancer UK research
More than 80% of men affected by prostate cancer experience erection problems. Research in the World Journal of Men’s Health, led by Prostate Cancer UK, shows evidence that erection medication can also improve serious conditions including stroke, diabetes and enlarged...
Solifenacin and mirabegron are safe and effective in combination
Antimuscarinic agents remain the mainstay of medical management of bladder overactivity. Limited somewhat by their tolerability, the new agent mirabegron, a β3-adrenoreceptor agonist, has been approved as an alternative. There is little known however about the possible synergistic effects of...
A phase II dose-ranging study of mirabegron in patients with OAB
This was a multinational, multicentre, randomised, double–blind, double-dummy, parallel group placebo- and active- controlled phase II study. The study enrolled 1108 men and women aged 18 and over. The criteria were: patients must have had overactive blader (OAB) symptoms for...
